These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11685462)

  • 1. Cytotoxic T lymphocyte and cDNA sequence analyses of the MHC class Ib molecule Qa1 in nonobese diabetic mice.
    Chun T; Hermel E; Gaskins HR; Aldrich CJ
    Immunogenetics; 2001 Aug; 53(6):506-10. PubMed ID: 11685462
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.
    Jaeckel E; Lipes MA; von Boehmer H
    Nat Immunol; 2004 Oct; 5(10):1028-35. PubMed ID: 15378058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
    de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
    Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta cell MHC class I is a late requirement for diabetes.
    Hamilton-Williams EE; Palmer SE; Charlton B; Slattery RM
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6688-93. PubMed ID: 12750472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
    DiLorenzo TP; Serreze DV
    Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the mechanism of the development of insulin-dependent diabetes mellitus and an attempt to prevent its onset by the functional T cell molecules].
    Yokono K; Nagata M; Moriyama K; Tsukamoto K; Miki M; Yoneda R; Tominaga Y; Okamoto N; Yasuda N; Amano K; Kasuga M; Yagita H; Okumura Y
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):618-21. PubMed ID: 9081729
    [No Abstract]   [Full Text] [Related]  

  • 10. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.
    Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC
    J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Pro)insulin-specific regulatory T cells.
    Harrison LC; Solly NR; Martinez NR
    Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
    Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
    J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL.
    Qin H; Trudeau JD; Reid GS; Lee IF; Dutz JP; Santamaria P; Verchere CB; Tan R
    Int Immunol; 2004 Nov; 16(11):1657-62. PubMed ID: 15466911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of CD44 isoforms in nonobese diabetic (NOD) mice.
    Milde KF; Alejandro R; Pastori RL
    Transplant Proc; 1995 Dec; 27(6):3409. PubMed ID: 8540022
    [No Abstract]   [Full Text] [Related]  

  • 15. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
    Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
    Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking autoimmune T cells in diabetes.
    Serreze DV; Leiter EH
    J Clin Invest; 2003 Sep; 112(6):826-8. PubMed ID: 12975466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
    Ma H; Kapp JA
    Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.